Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
University of Pittsburgh
Sahlgrenska University Hospital
Merck Sharp & Dohme LLC
AIDS Malignancy Consortium
Institut de Cancérologie de Lorraine
UNICANCER
AIDS Malignancy Consortium
Merck Sharp & Dohme LLC
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group
INSYS Therapeutics Inc
National Cancer Institute (NCI)